Bright Minds Biosciences Inc (DRUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,138 | -5,427 | -8,743 | -5,888 | -2,020 |
| Depreciation Amortization | 29 | 14 | 55 | 43 | 31 |
| Other Working Capital | 301 | -715 | 397 | -460 | -179 |
| Other Operating Activity | 1,830 | 1,955 | 2,077 | 938 | -561 |
| Operating Cash Flow | $-10,979 | $-4,172 | $-6,214 | $-5,367 | $-2,730 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 37 | 6 | 2,810 | 860 | 822 |
| Common Stock Repurchased | N/A | 0 | N/A | 1,872 | 1,803 |
| Other Financing Activity | 176,253 | 9,599 | 58,363 | 35,045 | 33,773 |
| Financing Cash Flow | $176,290 | $9,605 | $61,172 | $37,776 | $36,398 |
| Exchange Rate Effect | -9 | -1,030 | 224 | 609 | 1,123 |
| Beginning Cash Position | 60,432 | 59,470 | 4,089 | 4,136 | 3,984 |
| End Cash Position | 225,734 | 63,874 | 59,271 | 37,153 | 38,776 |
| Net Cash Flow | $165,302 | $4,404 | $55,182 | $33,018 | $34,792 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,979 | -4,172 | -6,214 | -5,367 | -2,730 |
| Free Cash Flow | -10,979 | -4,172 | -6,214 | -5,367 | -2,730 |